#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma Hypotransferrinaemia Neuroendocrine carcinoma metastatic Deafness Krabbe's disease Follicular lymphoma stage II Alport's syndrome Spinal muscular atrophy Behcet's syndrome Extra-osseous Ewing's sarcoma recurrent Chronic lymphocytic leukaemia Ataxia telangiectasia Superficial vein thrombosis Thalassaemia alpha Infective uveitis More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts Noonan syndrome – Trials in Disease Mantle cell lymphoma – Basic Information Alexander disease – Trials in Disease Haemolytic uraemic syndrome – Life with Disease Isodicentric chromosome 15 syndrome – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Paroxysmal nocturnal haemoglobinuria Soft tissue sarcoma Lennox-Gastaut syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Amantadine Hemisulfate [Al[18F]F]Fapi-74 Febuxostat SIPAVIBART Remifentanil Hydrochloride Riboflavin Bp Lutikizumab R-Azasetron Besilate Citric Acid Monohydrate Tovorafenib Brimonidine Tartrate DESMOPRESSIN ACETATE Etanercept RO7268489 Hydralazine Hydrochloride Gemtuzumab Ozogamicin BLEXIMENIB Zanamivir Tafamidis Resamirigene Bilparvovec More therapies…

    Learn about Your Condition

    Chronic hepatitis C Urethral valves Non-obstructive cardiomyopathy Vascular calcification Medulloblastoma recurrent Nocturia Osteomyelitis Myocardial infarction Transient ischaemic attack Subdural haematoma Pancreatic carcinoma recurrent Mucopolysaccharidosis Netherton's syndrome Hepatobiliary cancer Langerhans cell sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Carbon Dioxide versus Iodine Contrast in Patients with Abdominal Aortic Aneurysm Having Fenestrated Endovascular Repair

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Aortic aneurysm
    Investigated Drugs:
    • Iomeprol
    • Iohexol
    • Iodixanol
    Denmark Sweden

  • Testing benzydamine hydrochloride and dichlorobenzyl alcohol lozenges for relief of sore throat symptoms in patients with acute pharyngitis

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • 2,4 DICHLOROBENZYL ALCOHOL
    • BENZYDAMINE HYDROCHLORIDE
    Germany

  • A study testing pioglitazone for adults with non-segmental vitiligo to see if it works and is safe when used with light therapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Vitiligo
    Investigated Drugs:
    • Pioglitazone
    Italy

  • Comparing morphine and alfentanil for treating severe acute pain in adults before hospital admission

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • ALFENTANIL HYDROCHLORIDE
    • Morphine Hydrochloride
    France

  • Study of aldesleukin in children aged 4 to 6 years with autism spectrum disorder whose mothers had immune system activation during pregnancy

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Aldesleukin
    France

  • A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    • Multiple sclerosis
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    Finland
Previous Page
1 … 756 757 758 759 760 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!